Immunic, Inc. (IMUX)

8.13 +0.09 (+1.12%) USD  |  NASDAQ  |  Nov 11, 13:26
More

Immunic Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for IMUX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Sionna Therapeutics, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. --